Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.
Mol Oncol. 2022 Jun;16(11):2235-2259. doi: 10.1002/1878-0261.13193. Epub 2022 Mar 2.
Mol Oncol. 2022.
PMID: 35167193
Free PMC article.
Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review.
Albertí-Valls M, Megino-Luque C, Macià A, Gatius S, Matias-Guiu X, Eritja N.
Albertí-Valls M, et al.
Cancers (Basel). 2023 Dec 29;16(1):185. doi: 10.3390/cancers16010185.
Cancers (Basel). 2023.
PMID: 38201612
Free PMC article.
Review.
Item in Clipboard
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer.
Gatius S, Jove M, Megino-Luque C, Albertí-Valls M, Yeramian A, Bonifaci N, Piñol M, Santacana M, Pradas I, Llobet-Navas D, Pamplona R, Matías-Guiu X, Eritja N.
Gatius S, et al. Among authors: alberti valls m.
Cancers (Basel). 2022 Jun 8;14(12):2842. doi: 10.3390/cancers14122842.
Cancers (Basel). 2022.
PMID: 35740505
Free PMC article.
Item in Clipboard
Cite
Cite